Stocks and Investing
Stocks and Investing
Thu, February 4, 2016
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, February 3, 2016
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Michael Schmidt Initiated (BLUE) at Buy and Held Target at $67 on, Feb 3rd, 2016
Michael Schmidt of Leerink Swann, Initiated "bluebird bio, Inc." (BLUE) at Buy and Held Target at $67 on, Feb 3rd, 2016.
Michael has made no other calls on BLUE in the last 4 months.
There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $69 on, Monday, December 7th, 2015
These are the ratings of the 4 analyists that currently disagree with Michael
- Biren Amin of "Jefferies" Maintained at Strong Buy with Decreased Target to $96 on, Monday, December 7th, 2015
- Yanan Zhu of "Wells Fargo" Initiated at Buy on, Friday, December 4th, 2015
- Salveen Richter of "Goldman Sachs" Initiated at Strong Buy and Held Target at $165 on, Wednesday, November 18th, 2015
- Mark Breidenbach of "Oppenheimer" Initiated at Buy and Held Target at $162 on, Tuesday, October 20th, 2015